Subthreshold laser therapy guidelines for retinal diseases
- PMID: 35739241
- PMCID: PMC9674644
- DOI: 10.1038/s41433-022-02136-w
Subthreshold laser therapy guidelines for retinal diseases
Conflict of interest statement
JC has received consulting a speaker fees from Salutaris, Novartis, Allergan, and Biogen.
References
-
- Pei-Pei W, Shi-Zhou H, Zhen T, Lin L, Ying L, Jiexiong O, et al. Randomised clinical trial evaluating best-corrected visual acuity and central macular thickness after 532-nm subthreshold laser grid photocoagulation treatment in diabetic macular oedema. Eye. 2015;29:313–21. doi: 10.1038/eye.2015.1. - DOI - PMC - PubMed
-
- Wu Z, Luu CD, Hodgson LAB, Caruso E, Brassington KH, Tindill N, et al. Secondary and exploratory outcomes of the subthreshold nanosecond laser intervention randomized trial in age-related macular degeneration: a LEAD study report. Ophthalmol Retina. 2019;3:1026–34. doi: 10.1016/j.oret.2019.07.008. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
